Literature DB >> 2898655

Myocardial injury after interleukin-2 therapy.

S Osanto, F H Cluitmans, C R Franks, H A Bosker, F J Cleton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2898655     DOI： 10.1016/s0140-6736(88)92982-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

Review 1.  Metastatic renal cell cancer--is the outlook really improving?

Authors:  J Waxman; H Thomas
Journal:  Postgrad Med J       Date:  1990-06       Impact factor: 2.401

2.  The lethal effects of cytokine-induced nitric oxide on cardiac myocytes are blocked by nitric oxide synthase antagonism or transforming growth factor beta.

Authors:  D J Pinsky; B Cai; X Yang; C Rodriguez; R R Sciacca; P J Cannon
Journal:  J Clin Invest       Date:  1995-02       Impact factor: 14.808

3.  Impaired left ventricular filling rate induced by treatment with recombinant interleukin 2 for advanced cancer.

Authors:  G Fragasso; M Tresoldi; R Benti; M Vidal; M Marcatti; A Borri; C Besana; P P Gerundini; C Rugarli; S Chierchia
Journal:  Br Heart J       Date:  1994-02

Review 4.  Clinical toxicity of interleukin-2.

Authors:  T Vial; J Descotes
Journal:  Drug Saf       Date:  1992 Nov-Dec       Impact factor: 5.606

Review 5.  Side effects of cytokines approved for therapy.

Authors:  Brian A Baldo
Journal:  Drug Saf       Date:  2014-11       Impact factor: 5.606
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.